10 results
Acute Respiratory Distress Syndrome – ARDS: Clinical Cheat Sheet

An acute diffuse, inflammatory lung injury, leading to
Respiratory Distress Syndrome ... – ARDS: Clinical ... leading to increased pulmonary ... consistent with pulmonary ... #CriticalCare
It is important to recognize Acute Decompensated Heart Failure (ADHF) as more than just simply a
with presence of pulmonary ... have achieved negative ... acute coronary syndrome ... heartfailure #chf #criticalcare ... #pharmacology
Pain, Agitation, and Delirium (PAD) in the ICU
Addressing the ICU Triad (PAD) can be accomplished through
will vary with clinical ... Propofol infusion syndrome ... No pharmacologic ... Delirium #PAD #ICU #CriticalCare ... #diagnosis #management
Intern Pocket Cards - Antibiogram and Susceptibilities
VRE - MRSA - GRAM POSITIVES - GRAM NEGATIVES -
POSITIVES - GRAM NEGATIVES ... Stewardship: → What syndrome ... (Use clinical data ... #antibiotics #management ... #pharmacology
IDSA - Diabetic Foot Infections - Suggested Route, Setting, and Duration of Antibiotic Therapy, by Clinical
IDSA - Diabetic ... Antibiotic Therapy, by Clinical ... Syndrome Soft-tissue ... #antibiotics #pharmacology ... #management
IDSA Recommendations for Treating Coccidiodomycosis in HIV-AIDS
Treating Mild Infections (Such As Focal Pneumonia or asymptomatic patients
IDSA Recommendations ... Infection (Diffuse Pulmonary ... • Use until clinical ... Prevention #Treatment #management ... infections #HIVAIDS #pharmacology
Sjogren's Syndrome Overview

Epidemiology:
• F > M: 9:1
• 5-6th Decades (can be any age)

Autoimmune exocrinopathy multisystemic disease
salivary ducts Clinical ... Disease: • 10%-15% Pulmonary ... , INC risk PE, Pulmonary ... lubricants • Pharmacologic ... Rheumatology #Diagnosis #Management
IDSA Recommendations for Preventing and Treating Cryptococcosis in HIV-AIDS
Treatment for cryptococcosis consists of 3 phases: induction,
IDSA Recommendations ... as substantial clinical ... improvement and a negative ... Prevention #Treatment #management ... infections #HIVAIDS #pharmacology
Overview of antifungal agents benefits, weaknesses, and adverse effects in the treatment of Coccidioidomycosis.
Fluconazole - Low
, hypokalemia, negative ... tolerable • Limited clinical ... Coccidioidomycosis #coccidioides ... #valleyfever #management ... comparison #table #pharmacology
Antifungal agents benefits, weaknesses, and adverse effects in the treatment of Coccidioidomycosis
Fluconazole
 - Benefits: Low cost/tolerable
, hypokalemia, negative ... Weaknesses: Limited clinical ... Coccidioidomycosis #pharmacology ... #management #treatment ... #coccidioides